Harvard Bioscience (HBIO) Operating Expenses (2016 - 2025)
Historic Operating Expenses for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $11.8 million.
- Harvard Bioscience's Operating Expenses fell 1922.95% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.0 million, marking a year-over-year increase of 5872.42%. This contributed to the annual value of $61.0 million for FY2024, which is 498.62% down from last year.
- According to the latest figures from Q3 2025, Harvard Bioscience's Operating Expenses is $11.8 million, which was down 1922.95% from $12.4 million recorded in Q2 2025.
- Harvard Bioscience's 5-year Operating Expenses high stood at $61.9 million for Q1 2025, and its period low was $11.8 million during Q3 2025.
- Over the past 5 years, Harvard Bioscience's median Operating Expenses value was $15.9 million (recorded in 2023), while the average stood at $18.1 million.
- Its Operating Expenses has fluctuated over the past 5 years, first plummeted by 2748.92% in 2023, then soared by 26274.71% in 2025.
- Quarter analysis of 5 years shows Harvard Bioscience's Operating Expenses stood at $17.9 million in 2021, then dropped by 8.8% to $16.3 million in 2022, then fell by 1.52% to $16.0 million in 2023, then dropped by 12.73% to $14.0 million in 2024, then decreased by 15.54% to $11.8 million in 2025.
- Its Operating Expenses was $11.8 million in Q3 2025, compared to $12.4 million in Q2 2025 and $61.9 million in Q1 2025.